DiscoverHealthTech Deep DiveAdvantage acquires Nippon Pharmacy. Plans to delist shares for just under 100 billion yen. Pharmacy business falls into the red amid intensifying competition. Specialized pharmacies facing headwinds?
Advantage acquires Nippon Pharmacy. Plans to delist shares for just under 100 billion yen. Pharmacy business falls into the red amid intensifying competition. Specialized pharmacies facing headwinds?

Advantage acquires Nippon Pharmacy. Plans to delist shares for just under 100 billion yen. Pharmacy business falls into the red amid intensifying competition. Specialized pharmacies facing headwinds?

Update: 2025-08-04
Share

Description

This podcast episode discusses significant shifts in the Japanese healthcare industry. One key development is the acquisition of Nihon Chouzai, a major dispensing pharmacy chain, by investment funds, indicating a move towards private ownership to revitalize its struggling dispensing pharmacy business. This struggle is attributed to intense competition from drugstores and policy changes that disadvantage "gate-front" pharmacies, which rely heavily on prescriptions from single medical institutions. The sources also highlight advancements in healthcare technology, specifically the expansion of cloud-based health management systems by Mediment, which adds detailed reporting and expert consulting features, and Henry's successful funding round to expand its cloud-based electronic health record system for acute care hospitals, signaling increased competition and innovation in hospital DX.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Advantage acquires Nippon Pharmacy. Plans to delist shares for just under 100 billion yen. Pharmacy business falls into the red amid intensifying competition. Specialized pharmacies facing headwinds?

Advantage acquires Nippon Pharmacy. Plans to delist shares for just under 100 billion yen. Pharmacy business falls into the red amid intensifying competition. Specialized pharmacies facing headwinds?

Kazutaka Yoshinaga